DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer – Pipeline Review, H1 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, … Continue reading
Cet article Colorectal Cancer – Pipeline Review, H1 2018 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.